Effects of chronic and acute methylphenidate hydrochloride (Ritalin) administration on locomotor activity, ultrasonic vocalizations, and neuromotor development in 3- to 11-day-old CD-1 mouse pups

Developmental Psychobiology

Volumn 39, Issue 3, 2001, Pages 216-228

  Penner, Marsha R ^a   McFadyen, Melanie P ^a   Carrey, Normand ^a   Brown, Richard E ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Attention deficit hyperactivity disorder; Development; Mus musculus; Psychostimulant; Ritalin; Ultrasonic vocalizations

Indexed keywords

METHYLPHENIDATE;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; LOCOMOTION; MOTONEURON; MOTOR COORDINATION; MOTOR DEVELOPMENT; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEWBORN; NONHUMAN; VOCALIZATION;

ANIMALS; ANIMALS, NEWBORN; AROUSAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EXPLORATORY BEHAVIOR; INJECTIONS, SUBCUTANEOUS; METHYLPHENIDATE; MICE; MOTOR ACTIVITY; MOTOR SKILLS; SOCIAL ISOLATION; ULTRASONICS; VOCALIZATION, ANIMAL;

EID: 0034760481     PISSN: 00121630     EISSN: None     Source Type: Journal    
DOI: 10.1002/dev.1047     Document Type: Article

References (73)

1. Neurotransmitter transporters: Recent progress
2. Cardiovascular response of hyperactive children to methylphenidate
3. Brain development, VII. Human brain growth spans decades
4. Development of standardized test batteries for knockout and mutant mice
5. Developing standardized behavioral tests for knockout and mutant mice
6. A comparison of behavioral and anatomical measures of hydroxyurea induced abnormalities
7. Pharmacological treatment of psychiatric disorders in children and adolescents
8. Psychopharmacology across the lifespan: Focus on developmental pharmacodynamics
9. Effects of chronic methylphenidate administration on the locomotor and exploratory behavior of prepubertal mice
10. Longlasting psychotomimetic consequences of low-dose amphetamine exposure in rhesus monkeys
11. NAC-1, a rat brain mRNA, is increased in the nucleus accumbens three weeks after chronic cocaine self-administration
12. Psychotic side effects of psychostimulants: A 5-year review
13. The involvement of dopaminergic systems with stereotyped behavior patterns induced by methylphenidate
14. Ultrasonic calling in rodents: A new experimental approach in behavioral toxicology
15. The case of the missing methylphenidate
16. Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: A double-blind, crossover trial
17. Temporal organization of ultrasonic vocalizations in infant mice
18. Early development of infants exposed to drugs prenatally
19. Psychopharmacology of ADHD: Children and adolescents
20. Short-term side effects of stimulant medication are increased in preschool children with attention-deficit/hyperactivity disorder: A double blind placebo-controlled study
21. Reflex-ontogeny and behavioral development of the mouse
22. Childhood-onset schizophrenia: Brain MRI rescan after 2 years of clozapine maintenance treatment
23. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity
24. Intranasal abuse of prescribed methylphenidate
25. Affinities of methylphenidate for dopamine, norepinephrine, and serotonin transporters
26. Dose dependent characteristics of methylphenidate on different indices of rats' locomotor activity at the beginning of the dark cycle
27. Brain development, IX: Human brain growth
28. Attention-deficit hyperactivity disorder: The stimulants
29. The use of psychotropic medication in preschoolers: Indications, safety, and efficacy
30. A device to enable the automatic recording of rodent ultrasonic vocalizations
31. Development of the cerebral cortex: X. Cortical development and experience II
32. Chronic methylphenidate alters locomotor activity and dopamine transporters differently than cocaine
33. Cocaine-induced effects on isolation stress in neonatal rats
34. Pharmacokinetics and clinical effectiveness of methylphenidate
35. The role of methylphenidate in psychiatry
36. Inhibition of methylphenidate-induced behaviors in rats: Differences among neuroleptics
37. Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: Comparison with amphetamine
38. Effects of early postnatal alcohol exposure on learning in the developing rat: Replication with intubation method of delivery
39. Serotonin depletion during synaptogenesis leads to decreased synaptic density and learning deficits in the adult rat: A possible model of neurodevelopmental disorders with cognitive deficits
40. A comparison of the motor-activating effects of acute and chronic exposure to amphetamine and methylphenidate
41. A method for the routine assessment of fore- and hindlimb grip strength of rats and mice
42. The use of psychotropic medication in preschoolers: Some recent developments
43. Ultrasonic vocalizations by rat pups as an animal model for anxiolytic activity: Effects of serotonergic drugs
44. Effects of acute or chronic methamphetamine administration on ultrasonic vocalizations in preweanling rats
45. Ultrasounds in young rodents. I. Changes with age in albino mice
46. Subchronic methylphenidate treatment modifies c-fos expression in the cortico-amygdalo-striatal network
47. The time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats
48. Increasing effects of repetitive cocaine administration in rats
49. Assessment of chemicals using a battery of neurobehavioral tests: A comparative study
50. Dextroamphetamine: Cognitive and behavioral effects in normal prepubertal boys
51. Dextroamphetamine: Cognitive and behavioral effects in normal and hyperactive boys and normal men
52. Absence of tolerance to the behavioral effects of methylphenidate in hyperactive and inattentive children
53. Attention deficit/hyperactivity disorder - From brain dysfunction to behavioral
54. Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of the catecholamines of the brain
55. Behavioral characterization of d- and l-amphetamine: Neurochemical implications
56. Changes in brain norepinephrine associated with sensitization to d-amphetamine
57. Age-related changes in the cytoarchitectonics of the human sensorimotor cortex
58. Sensitization of mice to methylphenidate
59. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: Review and integration
60. Clinical psychopharmacology of AD/HD: Implications for animal models
61. A double-blind, crossover comparison of methylphenidate and placebo in adults with child-onset attention deficit hyperactivity disorder
62. Behavioral indices of neurotoxicology
63. Study design considerations in developmental neurotoxicity
64. Pediatric pharmacology and the interaction between drugs and the developing brain
65. A developmental test battery for neurobehavioral toxicity in rats: A preliminary analysis using monosodium glutamate calcium carrageenan and hydroxyurea
66. The open-field test: A critical review
67. Open-field procedures
68. IV. Role of serotonin and other neurotransmitter receptors in brain development: Basis for developmental pharmacology
69. Is there dose-dependent tolerance associated with chronic methylphenidate therapy in hyperactive children: Oral dose and plasma considerations
70. Serotonergic and catecholaminergic reuptake inhibitors have opposite effects on the ultrasound isolation calls of rat pups
71. The infant rat separation paradigm: A novel test for anxiolytics
72. Exogenous tyrosine potentiates the methylphenidate-induced increases in extracellular dopamine in the nucleus accumbens: A microdialysis study